Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| THH | TryHard | $17.45 | -$14.55 | -45.47% | 2.1M | $1.6B | $4.00$55.05 |
| MTVA | MetaVia | $3.42 | -$2.01 | -36.99% | 1.5M | $13M | $3.00$23.54 |
| AGEN | Agenus | $3.68 | -$1.00 | -21.37% | 44.9K | $159M | $1.38$7.34 |
| SDOT | Sadot Group | $2.59 | -$0.64 | -19.81% | 126.1K | $5.0M | $1.17$35.80 |
| AFJK | Aimei Health Technology | $46.20 | -$10.39 | -18.36% | 16K | $346M | $6.75$130.37 |
| DGNX | Diginex | $2.21 | -$0.46 | -17.11% | 3.3M | $537M | $0.45$39.85 |
| RDTL | GraniteShares ETF Trust - GraniteShares 2x Long Rddt Daily ETF | $49.58 | -$10.17 | -17.02% | 670.3K | - | $9.72$89.84 |
| BGL | Blue Gold | $2.17 | -$0.44 | -16.95% | 259.2K | $81M | $1.83$166.50 |
| FBYD | Falcon's Beyond Global | $7.20 | -$1.40 | -16.31% | 117.9K | $416M | $3.62$29.02 |
| TENX | Tenax Therapeutics | $15.68 | -$2.59 | -14.18% | 462.9K | $114M | $4.63$18.38 |
Related Articles
Featured Article
3 Magnificent Growth Stocks to Buy Hand Over Fist
George Budwell, PhD|May 22, 2024
Small-cap stocks could get a boost from the central bank's anticipated rate cuts in 2025. These three stocks may be a great way to get ahead of this catalyst.
Up 40%: Is This Red-Hot Growth Stock Still a Buy?
George Budwell, PhD|Apr 28, 2024
This small-cap biotech stock is surging. Time to buy?
Down 75%. Is Agenus Stock a Buy on the Dip?
Cory Renauer|Apr 8, 2024
Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.
Advertisement
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
George Budwell, PhD|Dec 24, 2023
These two biotech stocks could be poised for a trend reversal.
3 Magnificent Growth Stocks to Buy on the Dip
George Budwell, PhD|Aug 28, 2023
These three biotech stocks are attractive buys right now.
2 Low-Priced Stocks That Could Make You Richer
George Budwell, PhD|Jun 26, 2023
These two low-priced healthcare stocks could skyrocket within the next 12 months.
This Under-the-Radar Pharma Company Could Be a Bargain Hunter's Dream
Jeffrey Little|Oct 2, 2021
Pre-clinical successes lead to exclusive licensing agreements for iBio.
These 4 Micro-Cap Healthcare Stocks Gained the Most in 2020
Alex Carchidi|Jan 1, 2021
Innovation paid off big for investors.
Is It Too Late to Buy iBio Stock?
Zhiyuan Sun|Oct 29, 2020
The time to make money by investing in iBio is over. Here's why that's good news.
3 Popular Robinhood Stocks That Could Realistically Double Within 1 Year
Keith Speights|Oct 8, 2020
Here's what it would take.
